Torsemide,Furosemide
Not Tagged
[]
no benefit of #torsemide on primary endpoint whatever were the pre specified subgroups. similar rates of hospitalisations. on treatment analysis reported similar data. open label rct #transform hf #lbs1 #aha22 
President of CNCF. Member of the ACTION-Group. Associate Editor at Minerva Cardio-Angiology+Archives Med.Science-Scientific Director atAxis TV. tweets on my own